GoodRx vs Midi Health
GoodRx and Midi Health sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Midi Health
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Midi Health →If you are choosing between GoodRx and Midi Health, price alone will not settle it. GoodRx leads our six-part score, 6.9 to 4.6.
GoodRx vs Midi Health price
GoodRx publishes $149 a month. Midi Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
GoodRx lists tirzepatide and orforglipron; Midi Health does not name its drug.
On format, GoodRx prices brand-name pens, while Midi Health posts no priced format.
If you want the FDA-approved brand rather than a compounded version, GoodRx is the only one of the two with a brand-name price.
Where each one treats patients
GoodRx lists 50 states, and Midi Health lists 50 states.
They overlap in 50 states.
Pricing
GoodRx
Midi Health
Per-visit self-pay fee, NOT a monthly medication price; GLP-1 medication billed separately or through insurance. No compounded medication price is published on the current site.
Per-visit self-pay fee; medication not included. Under insurance you instead pay your standard copay + deductible.
What each price covers
Neither GoodRx nor Midi Health spells out what its price covers, so ask whether the visit, the drug and shipping are all in the monthly figure.
Where each one scores higher
Overall, GoodRx scores 6.9 and Midi Health 4.6 out of 10.
GoodRx is stronger on value (5.0 vs 3.0), effectiveness (10.0 vs 5.0), user experience (5.0 vs 2.5) and trust & safety (6.0 vs 5.0).
Accessibility and support are within half a point.
GoodRx
6.9/10
Midi Health
4.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither GoodRx nor Midi Health has an FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | Midi Health |
|---|---|---|
| Starting Price | $149/mo | Not published |
| Features | ✓6 features | 5 features |
| States Available | 50 | 50 |
| Compounded | — | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About Midi Health
Medicare, Medicaid, and Medi-Cal are all refused at Midi Health, though commercial insurance is taken. The platform covers menopause and perimenopause nationwide, in 50 states. GLP-1s are not sold here as a standalone weight-loss product; a clinician may add one at their discretion, a metabolic-health adjunct inside the menopause care framework.
Read our full Midi Health review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Midi Health
What we like
- Serves all 50 states
- We found no FDA warning letters issued to Midi Health
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
GoodRx wins this one, 6.9 to 4.6, above all for oral orforglipron alongside the injectables. Midi Health fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose Midi Health if…
You want coverage in all 50 states, which most sellers will not confirm.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →GoodRx vs Midi Health: FAQ
Close alternatives to GoodRx and Midi Health
- GoodRx vs Found
- GoodRx vs Kin Meds
- GoodRx vs PrideRx
- GoodRx vs PreventiveMD
- Midi Health vs Embody
- Midi Health vs TrimRx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.